COMMON GLEEVEC: A AFFORDABLE CHOICE?

The emergence of common imatinib represents a significant chance for patients battling a certain type of cancer and other illnesses. Original brand-name imatinib, branded as Gleevec, carries a steep price tag, frequently making it accessibility for some individuals. Generic versions, generally ma